Both Covishield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Austria, Estonia, Germany, Greece, Iceland, Ireland, Slovenia, Spain and Switzerland By UdaipurTimes Team Thu, 1 Jul 2021 Subsequent to Switzerland announcing that it will permit COVISHIELD administered Indian visitors, 7 other countries from European Union and Ireland have confirmed permission for Indian visitors who are administered COVISHIELD. The countries, as per sources, include Austria, Estonia, Germany, Greece, Iceland, Slovenia and Spain. Ireland also confirmed accepting COVISHIELD. The Green Pass, European Union’s Digital COVID Certificate will be in effect from today. Eu...

A select list of stories to read before you start your day. Both Covishield and Covaxin, while effective at generating an immune response against the coronavirus, appear to generate only half as many antibodies against the B.1.617 strain, or the Indian strain, according to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR). India’s COVID-19 situation remains hugely concerning, with several states continuing to see a worrying number of cases, hospitalisations and deaths, WHO chief Tedros Adhanom Ghebreyesus said on Friday, warning that the pande...

Reduced antibodies not a cause of worry on efficacy against COVID-19, say experts Both Covishield and Covaxin, while effective at generating an immune response against the coronavirus, appear to generate only half as many antibodies against the B.1.617 strain, or the Indian strain, according to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR). Several scientists told The Hindu that this drop didn't diminish the fact that the vaccines continued to be potent tool against COVID-19. Scientists at the ICMR-National Institute of Virology (NIV), Pune...

India gets third Covid-19 vaccine, how it may boost fight against coronavirus pandemic Prabhash K Dutta India on Monday approved Russian jab Sputnik V as the third Covid-19 vaccine for restricted use in the country. The vaccine was developed by the Gamaleya Research Institute (GRI) of Russia, and funded and promoted outside by the Russian Direct Investment Fund (RDIF). In India, the RDIF's partner is Dr Reddy's Laboratories, which conducted clinical trials - mandatory for approval - in India. Sputnik-V became the first vaccine to be announced last year for protection against ...